The Difference in Presentation Level of Variant Receptors in Female Breast Tissue in Macromastia and Micromastia
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
There are more and more macromastic women in Taiwan, which may due to the high cholesterol foods. Patients with macromastia not only suffered from physical problems but also psychological discomforts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Jan 2006
Shorter than P25 for phase_1
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 12, 2005
CompletedFirst Posted
Study publicly available on registry
September 15, 2005
CompletedStudy Start
First participant enrolled
January 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2006
CompletedSeptember 15, 2005
June 1, 2005
September 12, 2005
September 12, 2005
Conditions
Outcome Measures
Primary Outcomes (1)
difference in receptor expression level
Interventions
Eligibility Criteria
You may qualify if:
- patients receiving reduction mammoplasty
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Hao-Chih Tai, M.D.
National Taiwan University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- ECT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 12, 2005
First Posted
September 15, 2005
Study Start
January 1, 2006
Study Completion
August 1, 2006
Last Updated
September 15, 2005
Record last verified: 2005-06